$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
奈拉滨用法用量
2025-10-19 11:44:20
Check Details
奈拉滨国内上市了吗?
2025-10-19 11:44:20
Check Details
奈拉滨哪里有卖?
2025-10-19 11:44:20
Check Details
服用奈拉滨的禁忌和注意事项
2025-10-19 11:44:20
Check Details
奈拉滨国内有吗?
2025-10-19 11:44:20
Check Details
奈拉滨安全性及疗效
2025-10-19 11:44:20
Check Details
奈拉滨效果如何?
2025-10-19 11:44:20
Check Details
达沙替尼一般吃多久会产生耐药性?
2025-10-19 11:44:20
Check Details
达沙替尼在医保范围内吗?
2025-10-19 11:44:20
Check Details
达沙替尼用途和效果
2025-10-19 11:44:20
Check Details
达沙替尼进医保了吗?
2025-10-19 11:44:20
Check Details
服用达沙替尼的禁忌和注意事项
2025-10-19 11:44:20
Check Details
1
2
...
4870
4871
4872
4873
4874
4875
4876
...
10219
10220
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pretomanid Medication Guide: Core Agent in the BPaL Regimen for Drug-Resistant Tuberculosis
2
Can Fezolinetant Treat Depression? A Comprehensive Analysis of Menopause Medication and Mood
3
Fezolinetant Side Effects Complete Guide: Safety and Management for Menopausal Hot Flashes
4
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD): Efficacy, Side Effects, and Patient Treatment Guide
5
Brivaracetam Medication and Discontinuation Safety Guide
6
Mirogabalin Discontinuation Guide: Safe Tapering and Key Considerations
7
Pretomanid: A Breakthrough Nitroimidazole for Drug-Resistant Tuberculosis
8
Tildrakizumab: A Long-Acting Biologic Therapy for Moderate-to-Severe Plaque Psoriasis
9
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
10
Lusutrombopag: Complete Guide to Dosage, Administration and Clinical Monitoring
11
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
12
Onset Timeline and Efficacy Assessment of Margetuximab plus Chemotherapy in HER2-Positive Metastatic Breast Cancer